Genter Capital市政優質中期主動型ETF GENM 深 滬
等待開盤 02-18 09:30:00 美东时间
10.45
+0.030
+0.29%
華盛通- 最 高10.45
- 今 開10.40
- 成交量 6284股
- 最 低 10.40
- 昨 收 10.42
- 總市值 1985.50万
- 52周最高 10.69
- 市盈率 靜 --
- 換手率 0.33%
- 52周最低 9.637
- 委 比 88.68%
- 總股本 190.00万
- 歷史最高 10.69
- 量 比 0.62
- 振 幅 0.48%
- 歷史最低 9.5253
- 每 手 1
- 風險率 0.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Generation Mining Secures $750,000 Strategic Investment From Biigtigong Nishnaabeg
BRIEF-Generation Mining Secures $750,000 Strategic Investment From Biigtigong Nishnaabeg Feb 10 (Reuters) - Generation Mining Ltd GENM.TO : GENERATION MINING SECURES $750,000 STRATEGIC INVESTMENT FROM BIIGTIGONG NISHNAABEG Source text: ID:nBw54qdyDa Further company coverage: GENM.TO (( Reuters.Brief
02-10 20:16
BRIEF-Generation Mining Strengthens Technical Leadership For The Marathon Copper-Palladium Project
BRIEF-Generation Mining Strengthens Technical Leadership For The Marathon Copper-Palladium Project Jan 28 (Reuters) - Generation Mining Ltd GENM.TO : GENERATION MINING STRENGTHENS TECHNICAL LEADERSHIP FOR THE MARATHON COPPER-PALLADIUM PROJECT Source text: ID:nBwcdVSyJa Further company coverage: GENM
01-28 20:04
FOCUS-Drugmakers turn to AI to speed trials, regulatory submissions
FOCUS-Drugmakers turn to AI to speed trials, regulatory submissions Pharmaceutical companies describe AI benefits for tedious work Novartis says AI cut trial site selection from weeks to a two-hour meeting Drugmakers use AI to draft regulator-ready filings By Maggie Fick and Michael Erman SAN FRANCI
01-26 19:00
BRIEF-Genting Malaysia Says Genting New York LLC Awarded Casino License
Dec 16 (Reuters) - Genting Malaysia Bhd GENM.KL: NEW YORK LLC AWARDED CASINO LICENSE BY NY STATE GAMING COMMISSION GENTING NEW YORK LLC SELECTED FOR AWARD OF A COMMERCIAL CASINO LICENSE Further compan...
2025-12-16 12:42
UPDATE 2-Genting launches $1.6 billion bid for Genting Malaysia to gain control of casino arm
Malaysian conglomerate to take full control of casino, hospitality arm Offers to buy remaining shares at 9.8% premium Deal is worth 6.74 billion ringgit ($1.6 billion) Adds more details throughout fro...
2025-10-13 17:16
BRIEF-Genmab To Buy Merus For USD 8.0 Billion
Sept 29 (Reuters) - Genmab A/S GMAB.CO: GENMAB TO ACQUIRE MERUS, EXPANDING LATE-STAGE PIPELINE AND ACCELERATING INTO A WHOLLY OWNED MODEL GENMAB A/S - TO BUY MERUS FOR USD 8.0 BILLION GENMAB A/S - DEA...
2025-09-29 13:28
BRIEF-Genmab Says Phase 3 EPCORE FL-1 Clinical Trial Met Dual Primary Endpoints In Patients With R/R FL
Aug 7 (Reuters) - Genmab A/S GMAB.CO: GENMAB ANNOUNCES PHASE 3 EPCORE® FL-1 CLINICAL TRIAL MET DUAL PRIMARY ENDPOINTS IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) GENMAB - FDA H...
2025-08-07 23:34
BRIEF-Genting Malaysia Submission Of Downstate New York Commercial Casino License Bid
June 30 (Reuters) - Genting Malaysia Bhd GENM.KL: SUBMISSION OF DOWNSTATE NEW YORK COMMERCIAL CASINO LICENSE BID Further company coverage: GENM.KL ((Reuters.Briefs@thomsonreuters.com;))
2025-06-30 15:10
BRIEF-Genmab Says To Submit SBLA To FDA For Ecoritamab In 2025
May 1 (Reuters) - Genmab A/S GMAB.CO: GENMAB TO SUBMIT SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION (SBLA) TO U.S. FOOD AND DRUG ADMINISTRATION FOR EPCORITAMAB PLUS RITUXIMAB AND LENALIDOMIDE (R2) IN PA...
2025-05-02 08:17
BRIEF-Genmab To Vigorously Defend Alleged Claims Of Trade Secret Misappropriation By Abbvie Inc.
March 21 (Reuters) - Genmab A/S GMAB.CO: GENMAB TO VIGOROUSLY DEFEND ALLEGED CLAIMS OF TRADE SECRET MISAPPROPRIATION BY ABBVIE INC. Source text: ID:nGNX938XFw Further company coverage: GMAB.CO ((Reute...
2025-03-22 11:31
